openPR Logo
Press release

Global Topical Drug Delivery Market 2019 Projected Huge Growth by 2026: Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation

12-03-2019 04:37 AM CET | Health & Medicine

Press release from: Data Bridge Market Research

Topical Drug Delivery Market

Topical Drug Delivery Market

CAGR values are jumping for the good in the Topical Drug Delivery Market which in turn is making the sales, import, export, and revenue growth. The report provides a thorough analysis on what the conditions are for the Pharmaceutical industry because of the Global Topical Drug Delivery Market.

The report is also a detailed analysis of what the market definition, classifications, applications, and market trends are along with these it also provides with the market’s drivers and restraints by using the help of SWOT analysis.

The Global Topical Drug Delivery Market is highly dependent on the top players and brands this report provides with detailed company profiles of those players and brands and showing what their moves are when it comes to developments, product launches, joint ventures, mergers, and accusations, all the while also providing with figures for the forecast years of 2019-2026.

Get PDF Sample Copy of Global Topical Drug Delivery Market Report at https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-topical-drug-delivery-market

Global Topical Drug Delivery Market is expected to rise from its initial estimated value of USD 120.82 billion in 2018 to an estimated value of USD 240.76 billion by 2026, registering a CAGR of 9.00% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing preference for topical drug delivery.

Global Topical Drug Delivery Market By Product Type (Formulations,( {Topical (Solid, Liquid, Semi-Solid), Transdermal (Patches, Gels)}), Application of Drug (Skin Drug, Ophthalmic Drug, Rectal Drug, Vaginal Drug, Nasal Drug), End-User (Hospitals, Clinics, Home Healthcare, Diagnostic Centers, Others); Distribution Channel (Direct Tenders, Retail);Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026

Topical drug delivery is one of the most effective ways of drug delivery as it gives optimum therapeutic outcomes. Gradually, the topical drug delivery system has become increasingly important in the pharmaceutical industry. The pharmacological response, both the desired therapeutic effect and the undesired unfavourable effect of a drug is dependent on the concentration of the drug at the place of action, which in turn depends upon the dosage form and the extent of absorption of the drug at the site of action.

According to World Health Organization, there were an estimated 9.6 million deaths in 2018 due to cancer; Cancer is the second leading cause of death globally. About 1 in 6 deaths is due to cancer. These deaths could have been avoided with the availability of proper medical for healthcare procedures. This significant number is expected to act as a driver to the market growth

Few of the major competitors currently working in the nerve repair biomaterial market are

Galderma S.A. (Switzerland),
GlaxoSmithKline plc. (U.K.),
Valeant Pharmaceuticals International, Inc. (Canada),
Crescita Therapeutics Inc. (Canada),
Medpharm (U.K.),
3M (U.S.),
Bayer AG (Germany),
Novartis AG (Switzerland),
Janssen Global Services, LLC (U.S.),
Cipla Inc. (India),
West Pharmaceutical Services ,Inc (US),
Biofarmitalia s.r.l (Italy),
Pharmatek Laboratories, Inc. (US),
Stiefel Laboratories, Inc. (US),
Tapemark (US),
Acrux Limited (Australia),
Nitto Denko Corporation (Japan),
Skinvisible Pharmaceuticals, Inc. (us),
Mylan N.V. (US),
Pocono Coated Products LLC (US),
Lohmann Therapie-Systeme AG (Germany)

Market Drivers

There is high demand for prevalence of skin diseases is expected to act as a driver to the market growth

High growing preference for topical drug delivery is also expected to act as a driver to the market growth

There is increase in incidence of burn injuries is also expected to act as a driver to the market growth

Rising incidence of diabetes is also to drive the market

Market Restraints

Negative impact of product recalls is expected to restrain the market growth.

Enquire for Buying Global Topical Drug Delivery Market Report at https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-topical-drug-delivery-market

Segmentation: Global Topical Drug Delivery Market

By Product Type

Topical
Solid Topical Formulations
Suppositories
Powders
Semi-Solid Topical Formulations
Creams
Gels
Ointments
Pastes
Lotions
Liquid Topical Formulations
Solutions
Suspensions
Transdermal
Patches
Gels

By Application of Drug

Skin Drug
Ophthalmic Drug
Rectal Drug
Vaginal Drug
Nasal Drug

By End-User

Hospitals and Private Clinics
Home Care Settings
Other

By Distribution Channel

Direct Tenders
Retail

By Geography

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Key Developments in the Market:

In December 2018, Aclaris Therapeutics Acquired RHOFADE® from Allergan. RHOFADE cream was approved by the U.S. Food and Drug Administration (FDA) in 2017 for the topical treatment of persistent facial erythema (redness) associated with rosacea in adults. By this acquisition Aclaris to further strengthen itself in topical treatments.

In December 2018, Sun Pharma acquires Pola Pharma’s two manufacturing plants. Pola Pharma is a topical drug and injectables manufacture in Japan. By this acquisition sun Pharma to further strengthen its presence in Japan.

TABLE OF CONTENTS GLOBAL TOPICAL DRUG DELIVERY MARKET

1. INTRODUCTION
1.1. OVERVIEW OF GLOBAL TOPICAL DRUG DELIVERY MARKET 1.2. CURRENCY AND PRICING 1.3. LIMITATION 1.4. MARKETS COVERED

2. MARKET SEGMENTATION
2.1. MARKETS COVERED 2.2. GEOGRAPHIC SCOPE 2.3. YEARS CONSIDERED FOR THE STUDY 2.4. CURRENCY AND PRICING 2.5. RESEARCH METHODOLOGY 2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 2.7. SECONDARY SOURCES 2.8. ASSUMPTIONS

3. MARKET OVERVIEW
3.1. DRIVERS

3.1.1. RISING CASES OF ACUTE AND CHRONIC DISEASE 3.1.2. RISING AGING POPULATION 3.1.3. TECHNOLOGICAL ADVANCEMENTS AND INNOVATIONS 3.1.4. APPROVAL OF NEW DRUGS 3.1.5. BETTER OPPORTUNITY IN PHARMERGING MARKETS

3.2. RESTRAINTS

3.2.1. REGULATORY SCENARIO AND PRICING PRESSURE

3.3. OPPORTUNITY

3.3.1. ENERGING MARKET 3.3.2. RISING ACCEPTANCE FOR SELF-ADMINISTRATION OF DRUGS

3.4. CHALLENGES

3.4.1. PRODUCT RECALL 3.4.2. PENETRATION INTO THE SMALLER MARKETS

4. PREMIUM INSIGHTS 5. EXECUTIVE SUMMARY 6. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY TYPE
6.1. OVERVIEW

6.2. TRANSDERMAL DRUG DELIVERY SYSTEMS (TDDS) 6.3. TOPICAL DRUG FORMULATION, BY PRODUCT TYPE 6.4. LIQUID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE 6.5. SEMI SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE 6.6. SOLID TOPICAL DRUG FORMULATION, BY PRODUCT TYPE

7. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION
7.1. OVERVIEW 7.2. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY INDICATION 7.3. GLOBAL ANTI-INFECTIVE TOPICAL DRUG DELIVERY MARKET, BY INDICATION

8. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
8.1. OVERVIEW 8.2. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL

9. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY END USER
9.1. OVERVIEW

10. GLOBAL TOPICAL DRUG DELIVERY MARKET, BY GEOGRAPHY
10.1. OVERVIEW

10.2. NORTH AMERICA TOPICAL DRUG DELIVERY MARKET

10.2.1. U.S. TOPICAL DRUG DELIVERY MARKET 10.2.2. CANADA TOPICAL DRUG DELIVERY MARKET 10.2.3. MEXICO TOPICAL DRUG DELIVERY MARKET

10.3. EUROPE TOPICAL DRUG DELIVERY MARKET

10.3.1. GERMANY TOPICAL DRUG DELIVERY MARKET 10.3.2. FRANCE TOPICAL DRUG DELIVERY MARKET 10.3.3. ITALY TOPICAL DRUG DELIVERY MARKET 10.3.4. U.K. TOPICAL DRUG DELIVERY MARKET 10.3.5. SWITZERLAND TOPICAL DRUG DELIVERY MARKET 10.3.6. SPAIN TOPICAL DRUG DELIVERY MARKET 10.3.7. NETHERLAND TOPICAL DRUG DELIVERY MARKET 10.3.8. RUSSIA TOPICAL DRUG DELIVERY MARKET 10.3.9. TURKEY TOPICAL DRUG DELIVERY MARKET 10.3.10. BELGIUM TOPICAL DRUG DELIVERY MARKET 10.3.11. REST OF EUROPE TOPICAL DRUG DELIVERY MARKET

10.4. APAC TOPICAL DRUG DELIVERY MARKET

10.4.1. JAPAN TOPICAL DRUG DELIVERY MARKET 10.4.2. CHINA TOPICAL DRUG DELIVERY MARKET 10.4.3. SOUTH KOREA TOPICAL DRUG DELIVERY MARKET 10.4.4. INDIA TOPICAL DRUG DELIVERY MARKET 10.4.5. AUSTRALIA TOPICAL DRUG DELIVERY MARKET 10.4.6. SINGAPORE TOPICAL DRUG DELIVERY MARKET 10.4.7. THAILAND TOPICAL DRUG DELIVERY MARKET 10.4.8. MALAYSIA TOPICAL DRUG DELIVERY MARKET 10.4.9. INDONESIA TOPICAL DRUG DELIVERY MARKET 10.4.10. PHILIPPINES TOPICAL DRUG DELIVERY MARKET 10.4.11. REST OF APAC TOPICAL DRUG DELIVERY MARKET

10.5. SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET

10.5.1. BRAZIL TOPICAL DRUG DELIVERY MARKET 10.5.2. REST OF SOUTH AMERICA TOPICAL DRUG DELIVERY MARKET

10.6. MIDDLE EAST AND AFRICA (MEA) TOPICAL DRUG DELIVERY MARKET

10.6.1. SOUTH AFRICA TOPICAL DRUG DELIVERY MARKET 10.6.2. REST OF MEA TOPICAL DRUG DELIVERY MARKET

11. GLOBAL TOPICAL DRUG DELIVERY MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: GLOBAL

12. COMPANY PROFILES
12.1. GALDERMA PHARMA S.A.

12.1.1. COMPANY OVERVIEW 12.1.2. FINANCIAL OVERVIEW 12.1.3. PRODUCT PORTFOLIO 12.1.4. RECENT DEVELOPMENTS

12.2. HISAMITSU PHARMACEUTICAL CO., INC.

12.2.1. COMPANY OVERVIEW 12.2.2. REVENUE ANALYSIS 12.2.3. PRODUCT PORTFOLIO 12.2.4. RECENT DEVELOPMENTS

12.3. PFIZER INC.

12.3.1. COMPANY OVERVIEW 12.3.2. REVENUE ANALYSIS 12.3.3. PRODUCT PORTFOLIO 12.3.4. RECENT DEVELOPMENTS

12.4. ABBVIE INC.

12.4.1. COMPANY OVERVIEW 12.4.2. REVENUE ANALYSIS 12.4.3. PRODUCT PORTFOLIO 12.4.4. RECENT DEVELOPMENTS

12.5. BAYER AG

12.5.1. COMPANY OVERVIEW 12.5.2. REVENUE ANALYSIS 12.5.3. PRODUCT PORTFOLIO 12.5.4. RECENT DEVELOPMENTS

12.6. 3M

12.6.1. COMPANY OVERVIEW 12.6.2. REVENUE ANALYSIS 12.6.3. PRODUCT PORTFOLIO 12.6.4. RECENT DEVELOPMENTS

12.7. ANTARES PHARMA, INC.

12.7.1. COMPANY OVERVIEW 12.7.2. REVENUE ANALYSIS 12.7.3. PRODUCT PORTFOLIO 12.7.4. RECENT DEVELOPMENTS

12.8. VALEANT PHARMACEUTICALS INTERNATIONAL, INC.

12.8.1. COMPANY OVERVIEW 12.8.2. REVENUE ANALYSIS 12.8.3. PRODUCT PORTFOLIO 12.8.4. RECENT DEVELOPMENTS

12.9. ALLERGAN PLC.

12.9.1. COMPANY OVERVIEW 12.9.2. REVENUE ANALYSIS 12.9.3. PRODUCT PORTFOLIO 12.9.4. RECENT DEVELOPMENTS

12.10. KAKEN PHARMACEUTICALS CO., LTD

12.10.1. COMPANY OVERVIEW 12.10.2. REVENUE ANALYSIS 12.10.3. PRODUCT PORTFOLIO

13. RELATED REPORTS

View Detailed Table of Content at https://www.databridgemarketresearch.com/toc/?dbmr=global-topical-drug-delivery-market

Contact:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: Corporatesales@databridgemarketresearch.com

About Data Bridge Market Research

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Topical Drug Delivery Market 2019 Projected Huge Growth by 2026: Biofarmitalia s.r.l, Pharmatek Laboratories, Inc., Stiefel Laboratories, Inc., Tapemark, Acrux Limited, Nitto Denko Corporation here

News-ID: 1874909 • Views: 163

More Releases from Data Bridge Market Research

Electronic Adhesives Market to set Phenomenal Growth| Bondline Electronic Adhesi …
The Global Electronic Adhesives Market report provides an unbiased and detailed analysis of the on-going trends, opportunities/ high growth areas, market drivers, which would help stakeholders to device and align Electronic Adhesives market strategies according to the current and future market. The Electronic Adhesives Market report covers the Global market and regional market analysis. The industry report examines, keep records and presents the worldwide market size of the important players
Construction Equipment Market to set Phenomenal Growth| AB Volvo, Komatsu, Hyund …
The Global Construction Equipment Market report provides an unbiased and detailed analysis of the on-going trends, opportunities/ high growth areas, market drivers, which would help stakeholders to device and align Construction Equipment market strategies according to the current and future market. The Construction Equipment Market report covers the Global market and regional market analysis. The industry report examines, keep records and presents the worldwide market size of the important players
Carpets and Rugs Market Impressive Growth| Tarkett, Inter IKEA Systems, Interfac …
The Global Carpets and Rugs Market report provides an unbiased and detailed analysis of the on-going trends, opportunities/ high growth areas, market drivers, which would help stakeholders to device and align Carpets and Rugs market strategies according to the current and future market. The Carpets and Rugs Market report covers the Global market and regional market analysis. The industry report examines, keep records and presents the worldwide market size of
Seafood Processing Equipment Market Status Analysis and Forecast 2026 By ARCOS L …
Global Seafood Processing Equipment Market is expected to rise from its initial estimated value of USD 2.03 billion in 2018 to an estimated value of USD 2.68 billion by 2026, registering a CAGR of 3.51% in the forecast period of 2019-2026. Increase in the demand for the healthy food is the major factor for the growth of this market. seafood processing equipment market report comprises of historic data along with future

All 5 Releases


More Releases for DRUG

Biologics Drug Discovery Market
2019-2025 Biologics Drug Discovery Market Report with Depth Analysis The biologics drug discovery involves target identification, hit-to-lead stage, lead identification and optimization. The report presents a comprehensive overview, market size, shares, and growth opportunities of Biologics Drug Discovery market by product type, application, key manufacturers and key regions. Request For Free report Sample -https://www.reportsmonitor.com/request_sample/306320 Scope of the Report: Furthermore, Biologics Drug Discovery Market report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers or
Opioid Antagonist Drug Market
The global market has been prognosticated to earn demand from popular types of products such as external use, oral and applications such as household and hospital. The Company has made available another publication in its Healthcare archive of market intelligence reports, which is titled “Global Opioid Antagonist Drug Market Research Report 2018.” While the threat of substitutes and technological risks could have an unfavorable impact on the global market, potential
Drug and cosmetics
Drug and Cosmetics Conferences regards each one of the individuals to go to the On “Drug and Cosmetics” amidst October 17-October 18, 2018 in Toronto, Canada which melds brief keynote presentations, speaker talks, Exhibition, Symposia, Workshops. Drug and Cosmetics Congress is one of the meetings and conferences which will be visited by all the prestigious cosmetologists, Scientists, fiery inspectors, postgraduates, affiliations, business meanders under a solitary rooftop. DRug and cosmetics BLESSY MATHEW Program
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning